INTELLIA THERAPEUTICS INC (NTLA) Stock Cash Flow
USA - NASDAQ:NTLA - US45826J1051 - Common Stock
16.92 USD
+0.61 (+3.74%)
16.9 USD
-0.02 (-0.12%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -480.19M | -519.02M | -481.19M | -474.19M | -267.89M | |||
| Depreciation Amortization | 10.15M | 10.29M | 8.98M | 7.57M | 6.89M | |||
| Change In Working Capital | -66.67M | 11.88M | -52.45M | -53.87M | -22.90M | |||
| Other non cash items | 118.14M | 147.98M | 130.58M | 187.20M | 58.88M | |||
| OPERATING CASH FLOW | -418.58M | -348.88M | -394.09M | -333.29M | -225.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.23M | -5.78M | -13.98M | -13.56M | -12.76M | |||
| Other Investing Activity | 348.33M | 131.34M | -17.36M | 173.87M | -538.02M | |||
| INVESTING CASH FLOW | 345.09M | 125.57M | -31.35M | 160.31M | -550.78M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 99.16M | 185.75M | 130.32M | 582.96M | 736.69M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 99.16M | 185.75M | 130.32M | 582.96M | 736.69M | |||
| CHANGE IN CASH | 25.67M | -37.57M | -295.11M | 409.98M | -39.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -418.58M | -348.88M | -394.09M | -333.29M | -225.03M | |||
| Capital Expenditure | -3.23M | -5.78M | -13.98M | -13.56M | -12.76M | |||
| FREE CASH FLOW | -421.82M | -354.66M | -408.07M | -346.85M | -237.79M | |||
All data in USD